DR. CARTER ABEL

M.D.Real-Time Hydrated
Practice Location: ANNANDALE, NJ 08801
NPI Number: 1558347229
LIFETIME INDUSTRY VALUE
$394
2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ABEL is a verified Dermatology, MOHS-Micrographic Surgery practitioner based in ANNANDALE, NJ.

Between 2021 and 2025, Dr. ABEL had an overall industry promotional and research financial footprint of $394 as recorded in the federal CMS Open Payments database.

  • $394 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
  • $0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABEL's primary funding source is MERZ NORTH AMERICA, which accounts for $137 (representing 34.6% of overall industry footprint).

Data coverage: 2021 – 2025  ·  Source: CMS Open Payments  ·  CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments
Research Funding
$132$66$0$312021$1322022$1182023$542024$592025

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

MERZ NORTH AMERICA
Rank 1
$137
34.6%
ALLERGAN
Rank 2
$84
21.3%
REGENERON HEALTHCARE SOLUTIONS
Rank 3
$54
13.8%

General payments include consulting honoraria, promotional speaking fees, meals, travel, educational materials, and entertainment offsets.

PROMOTIONAL COUNT
Active
ESTIMATED COMPLIANCE RISK
Standard

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:
2025
2025
2024
2023
2022
2021
Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.